These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27748158)

  • 21. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
    Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
    Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and hep. B and C code of practice.
    Aust Nurses J; 1992 Jun; 21(11):25-6. PubMed ID: 1530513
    [No Abstract]   [Full Text] [Related]  

  • 23. Audit of bloodborne virus prevention activity with drug users seen in primary care.
    Weightman R; Walton R; Bury J
    Commun Dis Public Health; 2004 Dec; 7(4):301-5. PubMed ID: 15779794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of the use of health protective measures for the prevention of hepatitis B, hepatitis C and HIV infections].
    Crispo R; Varano A
    Prof Inferm; 1997; 50(1):35-6. PubMed ID: 9248464
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.
    Ruan Y; Liang S; Zhu J; Li X; Pan SW; Liu Q; Song B; Wang Q; Xing H; Shao Y
    Sex Transm Dis; 2013 Apr; 40(4):323-8. PubMed ID: 23486498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial epidemiology of HIV-hepatitis co-infection in the State of Michigan: a cohort study.
    Butt Z; Grady S; Wilkins M; Hamilton E; Todem D; Gardiner J; Saeed M
    Infect Dis (Lond); 2015; 47(12):852-61. PubMed ID: 26179757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Economic Burden of Hepatitis A, B, and C in South Korea.
    Shon C; Choi HY; Shim JJ; Park SY; Lee KS; Yoon SJ; Oh IH
    Jpn J Infect Dis; 2016; 69(1):18-27. PubMed ID: 25971325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Needlestick injury--risk and prevention of blood borne infections].
    Georgi AK; Ruef C; Rampini SK
    Praxis (Bern 1994); 2009 Oct; 98(20):1119-27, 1129; quiz 1128. PubMed ID: 19809974
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys.
    Mahfoud Z; Afifi R; Ramia S; El Khoury D; Kassak K; El Barbir F; Ghanem M; El-Nakib M; DeJong J
    AIDS; 2010 Jul; 24 Suppl 2():S45-54. PubMed ID: 20610948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress in monitoring blood safety.
    Epstein JS; Holmberg JA
    Transfusion; 2010 Jul; 50(7):1408-12. PubMed ID: 20636529
    [No Abstract]   [Full Text] [Related]  

  • 38. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 39. Establishing a viral hepatitis prevention and control program: Florida's experience.
    Baldy LM; Urbas C; Harris JL; Jones TS; Reichert PE
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):24-30. PubMed ID: 17542449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from HIV and hepatitis viruses.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S11-8. PubMed ID: 15450381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.